Pharmacy

Consumers who have felt too nervous to seek out a physician or pharmacist for naloxone can now purchase the lifesaving drug online.

The FDA has updated its list of off-patent drugs that don't have generic competitors. 

Five drug categories, including shortages of controlled substances, have affected hospitals the most in terms of cost and reallocation of resources, according to a new survey from Vizient.

Patent tactics preventing biosimilars from entering the market have cost the U.S. healthcare system $7.6 billion since 2015, according to a new whitepaper published by the Association for Accessible Medication's Biosimilars Council. 

Drug shortages are costing U.S. hospitals at least $359 million a year on labor costs alone, a new study from Vizient suggests. 

Two physicians and two registered nurses have been charged in a $400 million pharmacy scheme to defraud Tricare, Blue Cross Blue Shield and UnitedHealthcare of Mississippi, according to the Hattiesburg American.

A wide-reaching lawsuit unsealed June 24 claims Teva Pharmaceuticals, subsidiaries of Pfizer and 18 other major drugmakers conspired to fix prices for more than 100 drugs and used code words in emails and phone calls cover up their actions, according…

The average annual cost of 61 widely used specialty drugs for treating chronic conditions reached $78,871 in 2017, a number nearly triple the average annual cost for the same specialty drugs in 2006, according to a new AARP report. 

An Oklahoma judge has approved Teva Pharmaceuticals' revised $85 million settlement with the state resolving claims that the drugmaker helped fuel the opioid crisis, according to CNBC. 

Conatus Pharmaceuticals, a biotechnology company in San Diego, is implementing a restructuring plan that includes laying off 40 percent of its staff after its liver disease drug failed a midstage trial.